Clinton M. Hasenour

723 total citations
15 papers, 428 citations indexed

About

Clinton M. Hasenour is a scholar working on Physiology, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Clinton M. Hasenour has authored 15 papers receiving a total of 428 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Physiology, 9 papers in Molecular Biology and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Clinton M. Hasenour's work include Diet and metabolism studies (7 papers), Metabolism, Diabetes, and Cancer (6 papers) and Pancreatic function and diabetes (5 papers). Clinton M. Hasenour is often cited by papers focused on Diet and metabolism studies (7 papers), Metabolism, Diabetes, and Cancer (6 papers) and Pancreatic function and diabetes (5 papers). Clinton M. Hasenour collaborates with scholars based in United States, France and Russia. Clinton M. Hasenour's co-authors include David H. Wasserman, Freyja D. James, Jamey D. Young, Eric D. Berglund, Curtis C. Hughey, Jeffrey S. Bonner, Louise Lantier, Deanna P. Bracy, Benoı̂t Viollet and E. Patrick Donahue and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Diabetes.

In The Last Decade

Clinton M. Hasenour

14 papers receiving 425 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Clinton M. Hasenour United States 11 249 187 111 94 85 15 428
Gabriel G. Dorighello Brazil 14 206 0.8× 123 0.7× 89 0.8× 60 0.6× 52 0.6× 21 478
Yasuhiro Maeno Japan 11 195 0.8× 140 0.7× 61 0.5× 79 0.8× 141 1.7× 12 456
K. Staiger Germany 9 258 1.0× 218 1.2× 99 0.9× 234 2.5× 92 1.1× 11 584
Yeliz Angın Netherlands 11 282 1.1× 130 0.7× 106 1.0× 58 0.6× 42 0.5× 12 418
Oliver Kluth Germany 12 213 0.9× 112 0.6× 209 1.9× 75 0.8× 130 1.5× 17 525
Farah Lizotte Canada 11 178 0.7× 78 0.4× 88 0.8× 42 0.4× 78 0.9× 22 427
Ulrike Nitzgen Germany 10 195 0.8× 107 0.6× 102 0.9× 176 1.9× 96 1.1× 18 406
Maria Lytrivi Belgium 8 147 0.6× 77 0.4× 203 1.8× 71 0.8× 169 2.0× 14 420
Lucía Serrano Spain 8 252 1.0× 133 0.7× 51 0.5× 118 1.3× 56 0.7× 9 393
Jutta Haas Germany 10 176 0.7× 95 0.5× 99 0.9× 155 1.6× 94 1.1× 16 375

Countries citing papers authored by Clinton M. Hasenour

Since Specialization
Citations

This map shows the geographic impact of Clinton M. Hasenour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clinton M. Hasenour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clinton M. Hasenour more than expected).

Fields of papers citing papers by Clinton M. Hasenour

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clinton M. Hasenour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clinton M. Hasenour. The network helps show where Clinton M. Hasenour may publish in the future.

Co-authorship network of co-authors of Clinton M. Hasenour

This figure shows the co-authorship network connecting the top 25 collaborators of Clinton M. Hasenour. A scholar is included among the top collaborators of Clinton M. Hasenour based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clinton M. Hasenour. Clinton M. Hasenour is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
Bednarski, T., et al.. (2024). Pharmacological SERCA activation limits diet-induced steatohepatitis and restores liver metabolic function in mice. Journal of Lipid Research. 65(6). 100558–100558. 8 indexed citations
3.
Hasenour, Clinton M., et al.. (2024). Metabolic Fluxes in the Renal Cortex Are Dysregulated In Vivo in Response to High-Fat Diet. Diabetes. 73(6). 903–908. 2 indexed citations
4.
5.
Hasenour, Clinton M., Arion Kennedy, T. Bednarski, et al.. (2020). Vitamin E does not prevent Western diet-induced NASH progression and increases metabolic flux dysregulation in mice. Journal of Lipid Research. 61(5). 707–721. 15 indexed citations
6.
Hasenour, Clinton M., et al.. (2020). In Vivo Estimates of Liver Metabolic Flux Assessed by 13C-Propionate and 13C-Lactate Are Impacted by Tracer Recycling and Equilibrium Assumptions. Cell Reports. 32(5). 107986–107986. 31 indexed citations
7.
Pantalone, Kevin M., et al.. (2020). Cardiovascular outcomes trials with glucagon‐like peptide‐1 receptor agonists: A comparison of study designs, populations and results. Diabetes Obesity and Metabolism. 22(12). 2209–2226. 12 indexed citations
8.
Colhoun, Helen M., Clinton M. Hasenour, Matthew C. Riddle, et al.. (2020). 924-P: Exploring Potential Mediators of the Cardiovascular Benefit of Dulaglutide in REWIND. Diabetes. 69(Supplement_1). 2 indexed citations
9.
Hasenour, Clinton M., Freyja D. James, Curtis C. Hughey, et al.. (2017). Liver AMP-Activated Protein Kinase Is Unnecessary for Gluconeogenesis but Protects Energy State during Nutrient Deprivation. PLoS ONE. 12(1). e0170382–e0170382. 24 indexed citations
10.
Leamy, Alexandra K., Clinton M. Hasenour, Robert A. Egnatchik, et al.. (2016). Knockdown of triglyceride synthesis does not enhance palmitate lipotoxicity or prevent oleate-mediated rescue in rat hepatocytes. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1861(9). 1005–1014. 16 indexed citations
11.
Hasenour, Clinton M., et al.. (2015). Mass spectrometry-based microassay of2H and13C plasma glucose labeling to quantify liver metabolic fluxes in vivo. American Journal of Physiology-Endocrinology and Metabolism. 309(2). E191–E203. 65 indexed citations
12.
Hasenour, Clinton M., Curtis C. Hughey, Freyja D. James, et al.. (2014). 5-Aminoimidazole-4-carboxamide-1-β-d-ribofuranoside (AICAR) Effect on Glucose Production, but Not Energy Metabolism, Is Independent of Hepatic AMPK in Vivo. Journal of Biological Chemistry. 289(9). 5950–5959. 57 indexed citations
13.
14.
Hasenour, Clinton M., Eric D. Berglund, & David H. Wasserman. (2012). Emerging role of AMP-activated protein kinase in endocrine control of metabolism in the liver. Molecular and Cellular Endocrinology. 366(2). 152–162. 67 indexed citations
15.
Bonner, Jeffrey S., Louise Lantier, Clinton M. Hasenour, et al.. (2012). Muscle-Specific Vascular Endothelial Growth Factor Deletion Induces Muscle Capillary Rarefaction Creating Muscle Insulin Resistance. Diabetes. 62(2). 572–580. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gabriel G. Dorighello Breakdown of academic impact, for papers by Yasuhiro Maeno Breakdown of academic impact, for papers by K. Staiger Breakdown of academic impact, for papers by Yeliz Angın Breakdown of academic impact, for papers by Oliver Kluth Breakdown of academic impact, for papers by Farah Lizotte Breakdown of academic impact, for papers by Ulrike Nitzgen Breakdown of academic impact, for papers by Maria Lytrivi Breakdown of academic impact, for papers by Lucía Serrano Breakdown of academic impact, for papers by Jutta Haas
Rankless by CCL
2026